drug-drug conjugate NUV-1511

A drug-drug conjugate (DDC) composed of an as of yet undisclosed tumor-targeting agent conjugated to an as of yet undisclosed chemotherapeutic agent, with potential antineoplastic activity. Upon administration, DDC NUV-1511 targets and binds to the as of yet undisclosed receptor expressed in certain tumor types. The chemotherapeutic agent kills the cancer cells, through an as of yet unknown mechanism of action. DDCs may be able to increase efficacy while reducing systemic toxicity.